The following is a summary of “Multimodality Therapy Including Pleurectomy/Decortication in Pleural Mesothelioma: Long-Term Outcomes in 152 Consecutive Patients a Retrospective Cohort Study,” ...

The life expectancy for someone with malignant mesothelioma is usually 4-18 months after diagnosis, according to Penn Medicine. Life expectancy varies according to multiple factors, and treatments may ...

Malignant pleural mesothelioma (MPM) is an aggressive cancer, associated with poor prognosis. We assessed the feasibility of patient-derived cell cultures to serve as an ex vivo model of MPM.

Symptoms of mesothelioma may go unrecognized, as they are often similar to common illnesses. However, early detection of mesothelioma is key to extending your life expectancy. Mesothelioma takes ...

Clin Lung Cancer. 2010;11(1):30-35. A total of 294 treatment cycles were administered to the 62 patients, with a median number of 6 cycles per patient (range, 1–6 cycles). Of 62 patients, 56 ...

Continue reading to learn more about the possible symptoms of the most common type of mesothelioma cancer, a step-by-step guide to understanding how a mesothelioma diagnosis is performed ...

We are pleased to announce the dosing of the first patient in our Phase I ISM6331 clinical trial in mesothelioma and other solid tumors. We will also move forward to advance patient enrollment in ...

Background: Pleural mesothelioma (MPM) is an aggressive malignancy with an average patient survival ... and specific details regarding the tissue microarrays have been described (20). We excluded ...

Pleural and peritoneal mesothelioma has the same origin, similar histology and immunophenotypes. In this study, we analyzed the genes expression in GSE2549 and GSE112154 microarray datasets to ...